Co-Sponsored by the U.S. Food and Drug Administration
Organizing Committee
David S.
Lester, Ph.D., Pfizer Global Research &
Development, Ann Arbor, Michigan, USA
Jeffrey L. Evelhoch, Ph.D.,
Pfizer Global Research & Development, Ann Arbor, Michigan, USA
John R, Griffiths, M.B.B.S., D.Phil.,
St. George's Hospital Medical School, London, England, UK Nakissa Sadrieh, Ph.D.,
Food and Drug Administration, Rockville, Maryland, USA Liqun Wang, Ph.D.,
GlaxoSmithKline, ACCI, Addenbrooke's Hospital, Cambridge, England, UK John C. Waterton, Ph.D.,
AstraZeneca, Macclesfield, Cheshire, England, UK Steve C. R. Williams, Ph.D.,
Institute of Psychiatry, London, England, UK